Vivek Subbiah, MD
@viveksubbiah
Chief, Early-Phase Drug Development|@SarahCannonDocs
#Oncologist, #Phase1trials, #PrecisionMedicine. Tweets=My own.
ID: 3085571050
http://rb.gy/2h7jj 11-03-2015 03:24:25
28,28K Tweet
35,35K Followers
2,2K Following
FDA Grants Accelerated Approval to Dabrafenib Plus Trametinib for BRAF V600E+ Tumor-Agnostic Indication cancernetwork.com/view/fda-grant… via CancerNetwork®